Screening for Early Lung Cancer in Shanghai, China
Screening and Diagnosing for Early Lung Cancer in Shanghai Communities With Imaging Procedures
1 other identifier
interventional
3,000
1 country
1
Brief Summary
Imaging procedures including chest X-ray and low-dose computed tomography may be effective in lung cancer early detection. Yet it is unknown whether low-dose computed tomography combined with computer aided detection (CAD) is more effective than LDCT in screening of early lung cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2 lung-cancer
Started Jul 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 5, 2014
CompletedFirst Posted
Study publicly available on registry
July 9, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedDecember 18, 2014
November 1, 2014
3.2 years
July 5, 2014
December 16, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
The sensitivities of low-dose computed tomography and low-dose computed tomography with computer aided detection in detecting early lung cancer
A questionaire will be recorded for each subject, including demographics, smoking history and disease history, etc. If a pulmonary nodule was found, the location, shape, size, margin and density will be recorded. A subject with a suspected malignant nodule, which was detected either by a radiologist or computed-aiding detection software, will refer to a physician for further management. Finally, the sensitivities of radiologist or software detection will be calculated.
24months
Secondary Outcomes (2)
The false positive rates between low-dose computed tomography and low-dose computed tomography with computer aided detection will be compared
24months
Nodule detection rate
6 months
Study Arms (1)
High-risk individuals
EXPERIMENTALThe elder and heavy smokers, which are high-risk individuals for early lung cancer. These subjects will be examined using "Observer nodule detection" and " Computer-aided nodule detection".
Interventions
Computed-aided detection (CAD) software will be used to detect the nodules.
Eligibility Criteria
You may qualify if:
- Age of 55 to 74 years; smoking history of at least 30 pack-years; and if former smoker, have quit within 15 years
- Age 50 or older ,20 or more pack-year history of smoking, and one additional risk factor (occupational exposure, residential radon exposure, cancer history, family history of lung cancer, history of lung disease)
- Age 35 and one additional risk factor
- Ability to accept LDCT examination and sign informed consent form
You may not qualify if:
- Individuals with any symptoms suggestive of lung cancer (e.g., vigorous coughing, chest pain, weight loss, blood-stained sputum)
- Individuals with acute pulmonary abnormalities or those in poor health conditions or those have metallic implants or devices in the chest or back will be excluded due to the potential impact on the results as well as difficulty of acquiring the images.
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shanghai Changzheng Hospitallead
- Shanghai Zhongshan Hospitalcollaborator
- Shanghai Pulmonary Hospital, Shanghai, Chinacollaborator
- Fudan Universitycollaborator
- Ruijin Hospitalcollaborator
- Shanghai Public Health Clinical Centercollaborator
Study Sites (1)
Changzheng Hospital
Shanghai, Shanghai Municipality, 200003, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Shiyuan Liu, MD
Radiology Department of Shanghai Changzheng Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Shanghai Changzheng Hospital
Study Record Dates
First Submitted
July 5, 2014
First Posted
July 9, 2014
Study Start
July 1, 2014
Primary Completion
September 1, 2017
Study Completion
September 1, 2017
Last Updated
December 18, 2014
Record last verified: 2014-11